Holen Sie sich die Stockscreener-App
524.57
0.28%
-1.45
Handel nachbörslich:
526.00
1.43
+0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$526.02
Offen:
$529.87
24-Stunden-Volumen:
2.14M
Relative Volume:
0.96
Marktkapitalisierung:
$194.94B
Einnahmen:
$44.56B
Nettoeinkommen (Verlust:
$6.72B
KGV:
29.57
EPS:
17.7387
Netto-Cashflow:
$6.29B
1W Leistung:
-0.50%
1M Leistung:
+10.58%
6M Leistung:
-5.99%
1J Leistung:
+24.35%
1-Tages-Spanne:
$522.95
$538.40
1-Wochen-Bereich:
$514.29
$538.40
52-Wochen-Spanne:
$385.46
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
524.57 | 195.48B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
194.54 | 138.36B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
569.01 | 46.31B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
122.09 | 34.18B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
335.23 | 32.95B | 3.17B | 642.63M | 516.49M | 10.77 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-03-27 | Eingeleitet | DZ Bank | Buy |
| 2025-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2025-12-09 | Eingeleitet | Goldman | Buy |
| 2025-12-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-12-01 | Hochstufung | HSBC Securities | Hold → Buy |
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
South America Next Generation Sequencing eDNA Biomonitoring - openPR.com
Metagenomics Market Key Companies AnalysisMerck KGaA, Thermo - openPR.com
Automated Cell Culture Market Is Going to Boom |• Thermo Fisher Scientific • Merck KGaA - openPR.com
TD Cowen Lowers Thermo Fisher (TMO) Price Target, Keeps Buy Rating - Yahoo Finance
Thermo Fisher: Great Business Still Trading At A Risky Price Before Earnings (NYSE:TMO) - Seeking Alpha
Here's How Much $100 Invested In Thermo Fisher Scientific 20 Years Ago Would Be Worth Today - Benzinga
Unlocking Q1 Potential of Thermo Fisher (TMO): Exploring Wall Street Estimates for Key Metrics - Yahoo Finance
Thermo Fisher Scientific Launches Applied Biosystems PowerFlex Thermal Cycler for Advanced PCR Workflows - Digital Health News
Crispr Technology Market Is Booming So Rapidly | Merck KGaA, Thermo Fisher Scientific, Origene Technologies, Inc. - openPR.com
Thermo Fisher Mikroskop: Advanced Imaging Drives Life Sciences Innovation Now - AD HOC NEWS
Thermo Fisher Scientific’s (TMO) Dividend: Steady Payouts in a Growing Market - MSN
Thermo Fisher Scientific launches Applied Biosystems™ PowerFlex™ Thermal Cycler - BioSpectrum India
Ninety One North America Inc. Makes New Investment in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Stock Holdings Lifted by Ninety One SA Pty Ltd - MarketBeat
Merit Financial Group LLC Buys 3,934 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Proteomics Collaboration Advances Population Health Study - Technology Networks
OpenAI Launches GPT-Rosalind AI Model Tailored for Drug Discovery and Biology Research - MLQ.ai
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy? - Yahoo Finance
TMO Q1 Earnings Preview: Will Life Sciences Solutions Lead Results? - Eastern Progress
Thermo Fisher Introduces PowerFlex Thermal Cycler To Simplify Complex PCR Workflows - BioPharma APAC
Thermo Fisher Scientific Launches Applied Biosystems™ PowerFlex™ Thermal Cycler to Advance PCR Flexibility and Productivity - The Joplin Globe
Thermo Fisher Scientific Inc. $TMO Shares Purchased by KBC Group NV - MarketBeat
Lbp Am Sa Sells 56,190 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Transient Protein Expression Market Key Players | Thermo Fisher Scientific, Promega Corporation, Merck KGAA, Qiagen - openPR.com
Diversified Management Inc. Invests $1.85 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. $TMO Shares Sold by Consolidated Investment Group LLC - MarketBeat
Border to Coast Pensions Partnership Ltd Acquires 30,245 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Assetmark Inc. Raises Position in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific (TMO) to Release Quarterly Earnings on Thursday - MarketBeat
Thermo Fisher Scientific Experiences Revision in Stock Evaluation Amid Mixed Performance Indicators - Markets Mojo
Veterinary Infectious Disease Diagnostics Industry Analysis 2025–2031 | Key Players: IDEXX Laboratories, Inc., Zoetis, Thermo Fisher Scientific - industrytoday.co.uk
Transcend Capital Advisors LLC Sells 3,364 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Annex Advisory Services LLC Acquires 3,469 Shares of Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific Inc. stock rises Tuesday, outperforms market - MarketWatch
Thermo Fisher Scientific and PRECISE Partner on Singapore Proteomics Study - Clinical Lab Products
Barclays Adjusts Price Target on Thermo Fisher Scientific to $625 From $650, Maintains Overweight Rating - marketscreener.com
A Look At Thermo Fisher Scientific (TMO) Valuation After Recent Share Price Volatility - Yahoo Finance
Third View Private Wealth LLC Invests $4.06 Million in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand Real-World Data Capabilities - BioSpace
Thermo Fisher Scientific Inc (TMO) Shares Surge 3.6% -- What GF Score of 88 Tells Investors - GuruFocus
Thermo Fisher Scientific Inc. stock rises Monday, outperforms market - MarketWatch
Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report? - Yahoo Finance
Thermo Fisher Scientific’s PPD Clinical Research Business Collaborates with HealthVerity to Expand R - pharmiweb.com
Small Molecule Innovator API CDMO Market Outlook, 2026-2033Lonza Group, Novo Holdings (Catalent) and Thermo Fisher Scientific Lead the Growing Industry - Yahoo Finance UK
TD Cowen lowers Thermo Fisher stock price target on valuation reset - Investing.com
Thermo Fisher Scientific, HealthVerity Partner to Expand Real-World Data Capabilities - Contract Pharma
TD Cowen Adjusts Price Target on Thermo Fisher Scientific to $625 From $683, Maintains Buy Rating - marketscreener.com
Allergy Diagnostic Market by Product & Service, Test Type, Allergen, End User - GlobeNewswire Inc.
State of Alaska Department of Revenue Has $21.58 Million Stock Holdings in Thermo Fisher Scientific Inc. $TMO - MarketBeat
Goldman Sachs Adjusts PT on Thermo Fisher Scientific to $610 From $650, Maintains Buy Rating - marketscreener.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.49%
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):